Allurion Technologies (NYSE:ALUR) Releases Earnings Results

Allurion Technologies (NYSE:ALUR) posted its quarterly earnings results on Wednesday. The company reported ($7.00) EPS for the quarter, missing the consensus estimate of ($4.75) by ($2.25), Zacks reports.

Allurion Technologies Price Performance

NYSE:ALUR traded down $0.33 during trading hours on Wednesday, reaching $2.78. The company’s stock had a trading volume of 190,257 shares, compared to its average volume of 710,960. Allurion Technologies has a one year low of $2.15 and a one year high of $98.75. The business’s 50-day moving average is $4.01 and its 200-day moving average is $9.93. The company has a market cap of $13.33 million, a price-to-earnings ratio of -0.23 and a beta of -0.59.

Analysts Set New Price Targets

A number of research analysts have commented on the company. Roth Mkm restated a “buy” rating and issued a $16.00 target price on shares of Allurion Technologies in a research note on Friday, March 21st. Chardan Capital reissued a “neutral” rating and issued a $2.50 price target on shares of Allurion Technologies in a research note on Friday, March 21st.

About Allurion Technologies

Allurion Technologies Inc focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite.